Trial intelligence / Profile preview

Efficacy of Jasmate Toothpaste for Dentinal Hypersensitivity

NCT05852366Phase 3Completed

Sponsor
Dr. D. Y. Patil Dental College and Hospital
Start
May 2023
Primary completion
Jul 2023
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of Jasmate in Dentinal hypersensitivity (DH) (3 arms), sponsored by Dr. D. Y. Patil Dental College and Hospital. Primary endpoint: Change in dentinal hypersensitivity at 8 weeks. Started May 2023; status: completed.

02

Drugs

Jasmate
03

Conditions

Dentinal hypersensitivity (DH)

Beyond the preview

Go deeper on NCT05852366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05852366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call